Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sisram Medical Ltd. ( (HK:1696) ) has shared an announcement.
Sisram Medical Ltd announced that the commercialization of its product, DAXXIFY® (DaxibotulinumtoxinA-lanm), in Mainland China is progressing steadily. The company is actively working on regulatory filings, market access, and building a professional team to support the product’s launch, expressing strong confidence in its market potential.
More about Sisram Medical Ltd.
Sisram Medical Ltd is a company incorporated in Israel, operating in the medical industry. It focuses on the commercialization of medical products, with a particular emphasis on the Chinese market.
Average Trading Volume: 1,106,939
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.82B
For detailed information about 1696 stock, go to TipRanks’ Stock Analysis page.